EC Healthcare (2138) has a market capitalization of approximately HK$429M, trading at HK$0.36 on the HKSE. Market cap moves with the live share price.
EC Healthcare's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
EC Healthcare runs a net profit margin of -10.7%, a gross margin of 22.8%, and an operating margin of 7.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
EC Healthcare reported revenue of HK
EC Healthcare does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
EC Healthcare carries a debt-to-equity ratio of 0.91x and a current ratio of 0.91x, with a market beta of 1.03. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For EC Healthcare (2138) the key facts are: market cap HK$429M, revenue HK
Get EC Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.